1. Public vs. Private Company M&A: Core Differences
The acquisition of a public company and the acquisition of a private company share the same economic objective, but the legal process that surrounds each transaction differs in almost every respect. Public company deals operate within a regulatory architecture designed to protect dispersed shareholders who lack the negotiating leverage of a private business seller. That architecture imposes obligations on the target board, the acquirer, and the financial advisers that have no direct analogue in privately negotiated transactions.
The first distinction is disclosure. A public company acquisition requires the parties to prepare and file detailed disclosure documents with the SEC describing the transaction, its background, the board's analysis, the financial adviser's methodology, and all material relationships between the parties. Those documents are reviewed by the SEC staff, who may issue comment letters requiring revisions and additional disclosure before the process can proceed. The disclosure obligations are not merely procedural: they are a substantive legal standard, and material omissions or misstatements in the proxy statement or offering documents create liability under Section 14(a) of the Securities Exchange Act and SEC Rule 14a-9.
The second distinction is board duty. In a private company acquisition, the seller's board has broad discretion to accept or reject offers and to impose whatever conditions it negotiates without the enhanced scrutiny that Delaware courts apply to public company transactions. In a public company deal, the board's conduct is evaluated against fiduciary duty standards shaped by decades of Delaware case law, including the Revlon and Unocal doctrines, that prescribe specific processes and constrain the board's freedom to favor some outcomes over others. A board that fails to satisfy the applicable fiduciary standard faces personal liability exposure and the risk that the transaction will be enjoined.
The third distinction is the involvement of public shareholders. In a private deal, the seller negotiates directly, and the transaction closes without a shareholder vote unless the governing documents require one. In a public deal, a substantial or majority shareholder vote is typically required, and even shareholders who do not actively oppose the transaction have legal rights, including the right to seek appraisal of the fair value of their shares under Section 262 of the Delaware General Corporation Law. The litigation environment in public company M&A is correspondingly more demanding: a meaningful percentage of public company acquisitions attract shareholder litigation within weeks of announcement.
The fourth distinction is transaction speed. Public company mergers typically require three to four months from signing to closing due to the proxy statement review process and the notice period required for shareholder votes. Two-step tender offers can be faster, delivering consideration to tendering shareholders in approximately 20 business days after the tender offer opens, but still require SEC filings and a back-end merger to acquire the remaining minority. For a comparison of the major M&A deal structures applicable to both public and private transactions, that guide provides a comprehensive structural overview alongside this pillar.
2. Fiduciary Duties of the Target Board: Revlon and Unocal
Delaware corporate law imposes fiduciary duties of care and loyalty on corporate directors in all business decisions, but the standard of judicial review that applies to M&A transactions is not uniform. The review standard depends on whether the transaction involves a change of control, a defensive response to an acquisition threat, or a conflict of interest. Selecting the correct standard is the foundational analytical step in evaluating whether the target board's conduct in an M&A process satisfies its legal obligations.
The business judgment rule is the default standard of review. Under the business judgment rule, courts presume that directors acted on an informed basis, in good faith, and in the honest belief that the action taken was in the best interests of the company and its shareholders. Courts applying the business judgment rule will not second-guess the board's substantive judgment unless the plaintiff can rebut the presumption by showing bad faith, self-interest, or failure to inform. In M&A contexts, business judgment review applies to strategic decisions that do not involve a change of control and are not defensive measures adopted in response to a takeover threat.
The Revlon doctrine displaces the business judgment rule and imposes a more demanding obligation on the board when the company is being sold in a change of control transaction. The Delaware Supreme Court's 1986 decision in Revlon, Inc. v. MacAndrews and Forbes Holdings established that once the board decides to sell the company or initiates a process that will result in a change of corporate control, the board's role shifts from protecting the corporation as a going concern to obtaining the best available price for shareholders in the resulting sale. Under Revlon, the board may not take actions that favor one bidder over another without a rational justification for doing so, may not use deal protection devices to lock out competing bids unreasonably, and may not subordinate shareholder interests to the interests of management, employees, or other constituencies at the expense of the deal price.
Revlon duties are triggered in cash acquisition transactions and in transactions where the acquirer's shareholders will not constitute a majority of the combined company's stock. They are not triggered in stock-for-stock mergers of approximate equals where the target's shareholders receive stock in the surviving entity and continue to hold a diversified equity interest in a public company. The distinction matters because it determines whether the board is obligated to maximize deal price or is free to consider other factors in evaluating the transaction.
The Unocal standard applies when the board adopts defensive measures in response to an actual or threatened acquisition attempt. Under Unocal Corp. v. Mesa Petroleum Co., a board claiming the protection of the business judgment rule for a defensive measure must first show that it had reasonable grounds to believe a threat to corporate policy and effectiveness existed, based on good faith and reasonable investigation. If that threshold is satisfied, the defensive measure must be reasonable in relation to the threat posed. Measures that are coercive or preclusive exceed the bounds of Unocal and are invalid regardless of the board's stated justification. For the full treatment of how these standards interact with specific deal structures, the M&A transactions practice at Acquisition Stars counsels boards through this analysis at the earliest stages of a transaction process.
3. Deal Protection Devices: No-Shop, Matching Rights, and Break-Up Fees
Merger agreements routinely include a suite of deal protection provisions designed to give the acquirer confidence that the transaction will proceed to closing without disruption from a competing bid. These provisions operate as a package: each one reinforces the others, and the overall effect is to raise the cost and complexity of a successful competing offer. Delaware courts examine deal protection devices as a set under the Revlon and Unocal standards and will invalidate combinations that are collectively preclusive or coercive, even if no individual provision would be problematic standing alone.
The no-shop covenant is the foundational deal protection provision. It prohibits the target from soliciting, encouraging, or participating in discussions with potential competing acquirers after the merger agreement is signed. The no-shop does not eliminate the board's fiduciary duty to respond to an unsolicited proposal that constitutes or is reasonably likely to lead to a superior proposal, which is a standard concept defined in merger agreements to permit the board to engage with unsolicited bidders without breaching the covenant. The scope of the fiduciary out and the conditions under which the target may engage with an unsolicited bidder are heavily negotiated provisions that define the practical boundary of the no-shop's protection.
Matching rights give the initial acquirer the right to revise its offer to match any competing proposal that the target board determines is superior before the board can change its recommendation or terminate the merger agreement. Typical matching right provisions give the initial acquirer three to five business days to respond to notice of a superior proposal, with the negotiating period sometimes reset if the competing proposal is revised during the matching period. Matching rights are commercially significant because they allow the initial acquirer to retain the deal even if a competing bidder emerges, but they also create a process obligation for the target board to give good-faith notice of competing proposals and their material terms.
Break-up fees, also called termination fees, are cash payments the target must make to the acquirer if the merger agreement is terminated under specified circumstances, most commonly because the target's board changes its recommendation and the shareholders vote against the deal, because the target accepts a superior proposal, or because the transaction fails to close due to the target's breach. Break-up fees in public company transactions are typically sized between 2 and 4 percent of the transaction's equity value. Delaware courts have held that break-up fees within this range are not preclusive of competing bids and do not independently render the board's fiduciary decision unreasonable.
Reverse termination fees, paid by the acquirer to the target if the acquirer fails to close for specified reasons, are the mirror provision. Reverse termination fees are particularly important in transactions that require regulatory approval or that are contingent on debt financing, where the risk of non-closing due to acquirer-side failures is material. The sizing of the reverse termination fee, and whether it is the exclusive remedy for acquirer breach or one of several available remedies, is a central point of negotiation in leveraged acquisitions and in transactions with regulatory risk. For a deeper discussion of how these devices interact with antitrust risk, see the guide to HSR and antitrust in M&A.
4. Go-Shop Provisions
A go-shop provision is a contractual carve-out to the no-shop covenant that expressly permits the target board to actively solicit and negotiate with competing acquirers for a defined period after signing the initial merger agreement. The go-shop inverts the typical post-signing dynamic: instead of the no-shop covenant limiting the target to responding only to unsolicited approaches, the go-shop authorizes the target to run an active marketing process, share confidential information with potential competing bidders under appropriate confidentiality agreements, and negotiate with them on deal terms without breaching the merger agreement.
Go-shop periods typically run between 20 and 45 days from signing, though the length is negotiated based on the circumstances of the transaction and the amount of pre-signing market outreach the target conducted. During the go-shop period, the target's financial advisers contact potential strategic and financial acquirers, provide them access to a confidential information memorandum and data room, and solicit indications of interest. If a competing bidder emerges and submits a proposal that the board determines to be superior, the target may provide that bidder with the same data room access as the initial acquirer and negotiate toward a definitive agreement.
Go-shops typically include a reduced break-up fee for competing bidders that emerge during the go-shop period. A standard structure distinguishes between an "excluded party," meaning a bidder that submitted a proposal during the go-shop period that the board determined was reasonably likely to lead to a superior proposal, and all other potential acquirers. If the target terminates the merger agreement to accept a superior proposal from an excluded party, the break-up fee payable to the initial acquirer is reduced, often to approximately half the standard fee, reflecting the initial acquirer's reduced expectation of exclusivity given the go-shop process.
The go-shop's utility in satisfying Revlon duties is a matter of some debate in Delaware case law. Courts have held that a go-shop period can be part of a reasonable sale process, but have also emphasized that a go-shop does not automatically cure a flawed pre-signing process or an unreasonably restrictive deal protection package. A go-shop that is paired with a very short period, a high initial break-up fee, or extensive matching rights may not provide a meaningful opportunity for competing bids to emerge and therefore may not satisfy the board's Revlon obligations even if it nominally authorizes post-signing solicitation.
Go-shops are most common in take-private transactions sponsored by private equity firms, where the target board did not conduct a pre-signing auction and needs to demonstrate post-signing market validation of the price. They are less common in strategic acquisitions where the target ran a full pre-signing auction and the signing price was established through competitive bidding. The go-shop's role in validating deal price connects directly to the board's obligation to obtain and rely on a fairness opinion from an independent financial adviser, discussed in the valuation section below.
5. One-Step Merger vs. Two-Step Tender Offer
The choice between a one-step merger and a two-step tender offer is the most consequential structural decision in public company M&A after the deal economics are agreed. Each structure has distinct legal requirements, a different timeline from signing to closing, and different implications for deal certainty and shareholder litigation risk. The decision should be made before the merger agreement is drafted, because the structure determines the entire architecture of the transaction documentation and the regulatory filing sequence.
In a one-step merger, the parties execute a merger agreement, the target prepares and files a proxy statement with the SEC, the SEC reviews and clears the proxy statement, and the target mails the proxy statement to shareholders. Shareholders vote at a special meeting held at least 20 days after the proxy statement is mailed, and the merger closes after the shareholder vote is obtained and any required regulatory approvals are received. The one-step process typically takes three to four months from signing, and sometimes longer if the SEC has substantive comments on the proxy statement that require multiple rounds of review. The one-step structure is required when the consideration includes acquirer stock, because the issuance of acquirer stock requires registration under the Securities Act on a Form S-4 registration statement, which must be declared effective by the SEC before the proxy statement can be mailed.
In a two-step structure, the acquirer launches a tender offer to purchase shares directly from target shareholders. The tender offer must remain open for at least 20 business days under SEC rules, and during that period the acquirer and target file their respective tender offer documents (the Schedule TO and Schedule 14D-9) with the SEC. Shareholders tender their shares directly to the acquirer's depositary agent. If the tender offer is successful, the acquirer uses its newly acquired ownership stake to merge out the remaining minority shareholders in a back-end merger, typically without a shareholder vote if the acquirer has reached the threshold for a short-form merger under the applicable corporation statute.
Delaware's Section 251(h) enables a critical efficiency in two-step cash transactions. Under Section 251(h), if the acquirer accepts shares in a tender offer that, together with shares already owned by the acquirer, results in ownership of at least the same percentage of the target's outstanding shares as would be required to approve the merger at a shareholder meeting, the back-end merger can be completed without a shareholder vote immediately after the tender offer closes. This provision eliminates the need for a separate proxy statement and shareholder vote in cash tender offers where the acquirer achieves the Section 251(h) threshold, compressing the total deal timeline substantially compared to the one-step structure.
The two-step structure provides greater deal certainty in transactions where speed is important and the acquirer can offer an attractive premium that will motivate shareholders to tender. The one-step structure is more appropriate when the consideration includes acquirer stock that must be registered, when regulatory approvals are expected to take several months regardless of the shareholder approval timeline, or when the transaction involves a company incorporated outside of Delaware that does not have an equivalent of Section 251(h). For the detailed mechanics of how the tender offer process works within a two-step structure, see the dedicated guide to tender offers in public company M&A.
6. Tender Offers
A tender offer is an offer made directly to the target company's shareholders to purchase their shares at a specified price during a defined offer period. Tender offers are governed by Sections 13(d), 13(e), and 14(d) and (e) of the Securities Exchange Act and by the SEC's Regulations 13D and 14D, which establish detailed procedural requirements for conducting, amending, extending, and terminating a tender offer. The regulatory framework is designed to ensure that all shareholders have equal access to the offer and the same opportunity to make an informed decision about whether to tender.
The acquirer commences the tender offer by filing the Schedule TO with the SEC on the day the offer begins, which is also the day the offer materials are first distributed to shareholders. The Schedule TO contains the offer to purchase, the letter of transmittal through which shareholders tender their shares, and all other offer documents, including any agreement between the acquirer and the target board recommending that shareholders accept the offer. The SEC may review the Schedule TO and issue comments, but the review process for tender offers is conducted on a compressed timeline compared to proxy statement reviews, and the offer may proceed while the SEC comment process runs in parallel.
The target board is required to file a Schedule 14D-9 within ten business days after the tender offer commences. The Schedule 14D-9 contains the board's recommendation regarding the tender offer, the reasons for that recommendation, and the information required by Item 1000 of Regulation M-A, including any opinion of a financial adviser retained by the board regarding the fairness of the offer price. The board's recommendation and the fairness opinion are among the most scrutinized disclosures in a tender offer, because they are the primary basis on which shareholders evaluate whether to tender their shares.
Tender offer rules impose several structural requirements that apply regardless of the acquirer's negotiating preferences. All tendering shareholders must receive the same consideration. If the acquirer increases the offer price during the offer period, all shareholders who have already tendered must receive the higher price. The offer must remain open for at least 20 business days and for an additional ten business days after any increase in the offer price or decrease in the number of shares being sought. Shareholders have the right to withdraw tendered shares at any time before the offer expires, which means a shareholder who tenders and then receives a higher competing offer can withdraw and re-evaluate.
Any person who acquires more than 5 percent of the target's outstanding shares, whether through the tender offer or through open-market purchases, must file a Schedule 13D within ten days of crossing the threshold. Acquirers who already hold target shares at the time the tender offer commences must include those pre-existing holdings in the Schedule TO and manage them under the tender offer's anti-manipulation rules. The comprehensive tender offer guide covers the full procedural sequence, including proration mechanics, conditions to the offer, and the interaction between the tender offer and the back-end merger.
7. Proxy Solicitation and the Merger Vote
When a merger requires a shareholder vote, the target company must prepare and distribute a proxy statement that gives shareholders the information they need to evaluate the transaction and cast an informed vote. The proxy statement is governed by Section 14(a) of the Securities Exchange Act and SEC Regulation 14A, which prescribe the information that must be included, the manner in which the statement must be filed and distributed, and the timing requirements relative to the shareholder meeting date.
The proxy statement must describe the background of the merger negotiations in detail, including the key events in the negotiating process, the board's deliberations, the factors the board considered in approving the transaction, and the reasons the board concluded that the merger is advisable and in the best interests of shareholders. The background of the merger section is one of the most extensively reviewed portions of the proxy statement by the SEC and by plaintiffs' counsel in shareholder litigation, because omissions or vague characterizations of the negotiating process are a frequent basis for disclosure claims. Accurate, detailed disclosure of every material event in the merger process, including preliminary contacts, rejected approaches, and board committee deliberations, is essential.
The proxy statement must also disclose in full the methodology and analysis of the financial adviser that rendered a fairness opinion to the board. This disclosure, which is required by SEC rules and case law, includes each of the financial analyses performed by the adviser, the multiples and comparable companies or transactions used, the financial projections underlying each analysis, and the range of values produced by each methodology. The financial adviser disclosure is frequently the subject of SEC comment letters and shareholder litigation, and the proxy statement must present the adviser's analysis in sufficient detail that a reader can understand how the conclusions were reached and whether the methodology was reasonable.
The proxy statement is initially filed with the SEC as a preliminary proxy statement on Schedule 14A and is subject to SEC review. The SEC's Division of Corporation Finance typically issues comments within 30 days of filing, and the target must respond to each comment in writing. After the SEC clears the preliminary proxy statement, the company files the definitive proxy statement and mails it to shareholders. Under Delaware law, notice of the shareholder meeting must be given between ten and sixty days before the meeting, meaning the proxy statement must be mailed at least ten days before the meeting date.
If the merger consideration includes acquirer stock, the acquirer must register those shares under the Securities Act on a Form S-4 registration statement, which is combined with the proxy statement into a joint proxy statement/prospectus filed by both companies. The Form S-4 must describe the acquirer's business, financial condition, and risk factors in sufficient detail for shareholders to evaluate the value of the stock consideration, which adds substantial complexity to the disclosure process and extends the SEC review timeline. For a complete treatment of the proxy solicitation process, including the SEC comment letter response strategy and the interaction with ISS and Glass Lewis proxy advisory firms, see the guide to proxy solicitation and the merger vote.
8. Going-Private Transactions and Rule 13e-3
A going-private transaction is an acquisition or recapitalization in which an affiliate of a public company takes the company private, causing the company's securities to become deregistered under Section 12 of the Exchange Act or causing the company to suspend its reporting obligations under Section 15(d). The most common forms of going-private transactions are management buyouts, in which the company's management team partners with a private equity sponsor to acquire the public float, and sponsor-led take-privates, in which a private equity firm acquires a public company whose stock it has partially owned.
Rule 13e-3 and Schedule 13E-3 apply to any going-private transaction involving an affiliate of the issuer. The rule requires the affiliate conducting the transaction to file a Schedule 13E-3 with the SEC at the time the transaction is first publicly announced and to update it through completion. The Schedule 13E-3 requires extensive disclosure that goes beyond what a standard proxy statement or tender offer document requires, including a statement of the purposes and reasons for the transaction, all alternatives considered and why they were rejected, the effects of the transaction on the company and its unaffiliated shareholders, and the affiliate's position on the fairness of the transaction to those unaffiliated shareholders.
The fairness disclosure obligation under Rule 13e-3 is one of its most demanding features. The affiliate and every other filing person listed on the Schedule 13E-3 must state affirmatively whether they believe the transaction is fair or unfair to unaffiliated shareholders, and must support that conclusion with reasonably detailed analysis. The fairness opinion from an independent financial adviser is typically incorporated by reference in the fairness discussion, but the opinion alone is not sufficient. The filing person must address the specific factors listed in Item 1014 of Regulation M-A, including the price relative to current market price and historical trading range, the net book value, going-concern value, and liquidation value, and any other independent analyses of the transaction's fairness.
The Delaware fiduciary duty analysis in going-private transactions is particularly complex because the transaction involves an inherent conflict of interest: the management or controlling shareholder on the buy side of the transaction has access to material non-public information about the company's value that public shareholders do not have, and has an economic incentive to pay as low a price as possible. Delaware courts apply the entire fairness standard of review to going-private transactions involving a controlling shareholder unless the MFW cleansing framework is satisfied, shifting the burden to the defendants to prove that the transaction was entirely fair to minority shareholders in both process and price.
Management buyout transactions present additional complications, because the management team's participation on the buy side creates a conflict of interest that affects both the independence of the board's evaluation process and the legal sufficiency of the market check. Special committee formation, independent financial adviser retention, and deliberate separation of management's buy-side activities from the board's fiduciary process are essential structural safeguards in any MBO. For the complete legal framework governing going-private transactions and the Schedule 13E-3 filing requirements, see the dedicated guide to going-private transactions and Rule 13e-3.
9. SEC Filing Landscape: S-4, 14A, 14D-9, SC TO, and SC 13E-3
The SEC filing requirements in a public company acquisition form an interconnected set of documents, each serving a distinct regulatory purpose and governed by specific rules under the Securities Act and the Securities Exchange Act. Understanding which filings are required, who must make them, and when they must be filed is a threshold compliance task that must be mapped to the specific transaction structure at the outset of the legal process.
The Form S-4 registration statement is required whenever an acquirer issues its own securities as consideration in a merger. The S-4 registers those securities under the Securities Act and incorporates the proxy statement and prospectus into a single joint document. The Form S-4 must contain prospectus-level disclosure about the acquirer, including audited financial statements for the prior three years, management's discussion and analysis, a description of the securities being issued, and risk factors relating to the combined company. The S-4 is filed by the acquirer, must be declared effective by the SEC before it can be used, and triggers an SEC review process that runs in parallel with the target's proxy statement review.
The Schedule 14A is the proxy statement form used by the target company in a one-step merger to solicit shareholder votes in favor of the transaction. It is filed initially as a preliminary proxy statement, reviewed by the SEC, and then filed as a definitive proxy statement after SEC clearance. The Schedule 14A contains the background of the merger, the board's recommendation, the reasons for the recommendation, the fairness opinion, the merger agreement as an exhibit, and all other information material to a shareholder's voting decision. In a transaction with Form S-4 registration of acquirer stock, the S-4 and 14A are combined into a joint proxy statement/prospectus filed on Form S-4 by the acquirer with incorporation by reference from the target's filings.
In a tender offer, the acquirer files the Schedule TO on the commencement date of the offer, and the target files the Schedule 14D-9 within ten business days thereafter. The Schedule TO contains the full offer to purchase and all related documents, and must be amended to reflect any material changes during the offer period, including any price increases, extensions, or new conditions. The Schedule 14D-9 contains the target board's recommendation and the supporting analysis, including the fairness opinion. Both documents are reviewed by the SEC concurrently with the tender offer period, and comment letters from the SEC must be responded to and resolved before the offer can be completed.
The Schedule 13E-3 is filed whenever a going-private transaction is undertaken by an affiliate of the issuer, as described in the previous section. In transactions that are both a tender offer and a going-private transaction, the Schedule 13E-3 is combined with the Schedule TO into a joint filing that satisfies both requirements. Managing the filing sequence, the SEC comment response process, and the disclosure obligations across multiple simultaneous filings is one of the most complex project management tasks in public company M&A, and requires experienced securities counsel coordinating with investment bankers, accountants, and the client's internal legal team. This practice intersects directly with the securities offerings work that Acquisition Stars conducts alongside M&A transactions.
10. Market Check and Strategic Review Processes
A market check is the process by which a target board satisfies itself that the price offered by a prospective acquirer represents the best available value for shareholders. Under Revlon, the board's obligation is to obtain the best available price, not merely to accept a fair price. A well-documented market check is the primary evidence that the board satisfied this obligation, and the adequacy of the market check is one of the central issues in shareholder litigation challenging the deal price or the board's process.
Market checks take two principal forms: a pre-signing auction and a post-signing go-shop. In a pre-signing auction, the target's investment banker contacts potential strategic and financial acquirers before the company executes a merger agreement with any party, solicits preliminary indications of interest, and narrows the field to a smaller group that receives access to the company's confidential information through a structured process. The final bidders submit binding or near-binding proposals, and the board selects the highest and best offer before signing any merger agreement. A fully competitive pre-signing auction is the strongest available evidence that the agreed price represents the maximum available value.
In situations where a target agrees to a negotiated transaction without a formal pre-signing auction, the go-shop period described in Section 4 provides a post-signing market check. Courts have held that a go-shop can satisfy Revlon in appropriate circumstances, but have also scrutinized whether the go-shop period was long enough, whether the financial adviser contacted a sufficient number and type of potential bidders, whether the deal protection provisions were structured to permit competing bids to emerge, and whether the initial deal price left enough room above it for a competing bidder to justify paying the break-up fee and winning a bidding contest.
Strategic review processes that precede a formal sale decision present a different set of considerations. A board that has been approached by a potential acquirer and instructs management to evaluate strategic alternatives is not yet in Revlon mode: the board retains discretion to decide whether to sell, continue as a standalone company, or pursue a different strategic path. The board's deliberations during this preliminary phase must be documented carefully, because the proxy statement will ultimately describe the entire process from the first contact through signing, and any gaps or inconsistencies in that narrative create litigation exposure.
The quality of the board's market check has a direct impact on the level of scrutiny that shareholder litigation applies to the transaction. Courts are more deferential to boards that ran fully competitive processes with multiple active bidders than to boards that accepted a negotiated proposal without testing the market. From a litigation risk perspective, investing in a thorough market check before signing is far less costly than defending a challenge to the adequacy of the process after the deal is announced. For the intersection of market check obligations and antitrust pre-clearance strategy, see the guide to HSR and antitrust compliance in M&A.
11. Valuation, Fairness Opinions, and Banker Letters
A fairness opinion is a written opinion rendered by an investment banking firm to the board of a company in connection with an M&A transaction, expressing the adviser's view that the consideration to be received or paid in the transaction is fair to the shareholders, from a financial point of view, as of the date of the opinion. Fairness opinions are not legally required in public company transactions, but they are standard practice and expected by Delaware courts evaluating whether the board's approval of a transaction was an informed decision made in good faith. A board that approves a significant M&A transaction without obtaining a fairness opinion from an independent financial adviser exposes itself to the inference that it was uninformed about the financial adequacy of the price.
The financial analyses underlying a fairness opinion typically include a discounted cash flow analysis based on management's financial projections, a comparable public company trading analysis, a comparable precedent transaction analysis, and, where applicable, a leveraged buyout analysis showing what a financial buyer could pay for the company while achieving its return thresholds. Each analysis produces a range of values, and the adviser concludes that the merger consideration falls within or above the range of values produced by the analyses collectively. The proxy statement must disclose each of these analyses in sufficient detail that shareholders can understand the adviser's methodology, and the management projections used in the DCF analysis must be disclosed as well.
The management projections underlying the fairness opinion are among the most litigation-sensitive disclosures in a proxy statement. Plaintiffs in merger litigation frequently challenge the reasonableness of projections that supported a DCF range favorable to the deal price, arguing that management's optimistic projections understated the company's intrinsic value and allowed the financial adviser to produce a fairness opinion at a price lower than true fair value. Defendants must demonstrate that the projections were prepared in the ordinary course of business and not created for the purpose of supporting the deal, and that the board reviewed and approved the projections after appropriate deliberation.
Banker letters, distinct from the formal fairness opinion, may include a "bring-down" letter confirming that the adviser's opinion remains valid as of the closing date, or an "11(a)(2)" letter in the context of registered securities offerings in which the banker confirms certain financial information in the registration statement. In going-private transactions subject to Rule 13e-3, the fairness opinion must address the transaction's fairness to unaffiliated shareholders specifically, which may require additional analysis and a different framing than a standard fairness opinion delivered to the full board.
The independence of the financial adviser is a significant issue in transactions where the adviser has ongoing business relationships with the acquirer or where the adviser's fee is structured as a success fee payable only if the transaction closes. Delaware courts have examined cases where the adviser's financial incentives to support the deal were insufficiently disclosed and have required proxy statements to describe the adviser's fee arrangements, its other engagements with the acquirer and the target, and any conflicts of interest that the board considered in evaluating the opinion. For cross-border transactions where multiple jurisdictions' valuation norms apply, see the guide to cross-border M&A for how fairness standards differ across jurisdictions.
13. DGCL Sections 251, 253, and 262 Mechanics
Delaware corporate law provides the statutory framework within which most public company mergers are structured, because the majority of U.S. public companies are incorporated in Delaware. The mechanics of the merger, the shareholder vote requirements, the procedures for back-end mergers, and the appraisal rights available to dissenting shareholders are all governed by the Delaware General Corporation Law, and specifically by Sections 251, 253, and 262 of that statute. Counsel advising on a public company merger must be fluent in these provisions and in the case law interpreting them.
Section 251 governs mergers of Delaware corporations generally. Under Section 251, a merger must be approved by the board of directors of each constituent corporation and, unless a specific exception applies, by the shareholders of each constituent corporation. The board adopts a resolution approving the merger agreement and resolves to submit the agreement to a shareholder vote. Shareholders approve the merger by the affirmative vote of the holders of a majority of the outstanding shares entitled to vote, unless the certificate of incorporation requires a higher percentage. Section 251(h) provides the streamlined back-end merger mechanism for tender offer transactions in which the acquirer has reached the required ownership threshold through the tender offer, as described in the one-step versus two-step discussion above.
Section 253 authorizes a short-form merger in which a parent corporation owning at least 90 percent of a subsidiary's outstanding shares of each class can merge the subsidiary into the parent without a shareholder vote of the subsidiary. The short-form merger is completed by the parent's board of directors adopting a resolution and filing a certificate of merger with the Delaware Secretary of State, without any vote by the subsidiary's public shareholders. Short-form mergers are significantly faster than long-form mergers and are used as the back-end mechanism in tender offers where the acquirer reaches the 90 percent threshold. The subsidiary's minority shareholders who do not tender in the tender offer receive the same merger consideration as tendering shareholders but have appraisal rights to seek judicial valuation of their shares.
Section 262 provides appraisal rights to shareholders who do not vote in favor of certain mergers, entitling them to seek a judicial determination of the fair value of their shares in lieu of accepting the merger consideration. To perfect appraisal rights, a shareholder must provide written demand before the merger vote, refrain from voting in favor of the merger, and continue to hold the shares through the effective time of the merger. After the merger is effective, the dissenting shareholders initiate an appraisal proceeding in the Delaware Court of Chancery. The Court's determination of fair value may be higher or lower than the merger consideration, and interest accrues on the appraisal award at a statutory rate.
The market out exception to appraisal rights provides that shareholders of a Delaware corporation do not have appraisal rights if their shares are listed on a national securities exchange and they receive consideration consisting entirely of cash, shares of the surviving corporation, shares of another corporation listed on a national securities exchange, or a combination thereof. This exception eliminates appraisal rights in the majority of cash tender offer back-end mergers, because the tendering shareholders have already received their consideration, and the remaining minority receives the same cash price in the short-form merger. Appraisal rights remain available in mergers where the consideration is less liquid or where the exception's conditions are not satisfied. For how appraisal rights interact with cross-border deal structures, see the cross-border M&A guide.
14. MFW Cleansing for Controller Conflicts
Transactions between a public company and its controlling shareholder occupy the most legally challenging territory in Delaware M&A law. A controlling shareholder on both sides of a transaction, whether as buyer in a take-private or as a dominant seller, is presumed to have interests that conflict with those of the minority shareholders. Delaware's default rule in such transactions is entire fairness review, under which the defendants must demonstrate that the transaction was entirely fair to minority shareholders in both process and price. Entire fairness is a demanding standard: it requires proof that the process was fair, that the price was fair, and that the combination of both elements was fair, with each element evaluated independently.
The MFW framework, established by the Delaware Supreme Court in Kahn v. M&F Worldwide Corp. and subsequently confirmed in Corwin v. KKR Financial Holdings and later cases, provides a procedural path for controller transactions to receive the more deferential business judgment rule review rather than entire fairness. To qualify for MFW protection, the controller must condition its proposal, at the outset, on two procedural safeguards operating simultaneously: approval by an independent special committee of the target board that has the authority to say no to the transaction, and approval by a majority of the minority shareholders in a fully informed and uncoerced vote.
The requirement that both conditions be imposed ab initio is critical. The Delaware courts have held that conditioning the transaction on one safeguard but not both, or conditioning the transaction on both safeguards only after negotiations have commenced under the shadow of the controller's proposal, does not satisfy MFW and leaves the transaction subject to entire fairness review. The controller's initial proposal to the target board must expressly condition the transaction on both safeguards before any substantive negotiations proceed, and this conditioning must be documented clearly in the board minutes and the subsequent proxy statement background section.
The special committee must be composed of directors who are independent from the controlling shareholder, must have its own legal and financial advisers retained independently rather than sharing the company's existing advisers who may have relationships with the controller, must have full authority to negotiate the terms of the transaction, must have the authority to reject the proposal and end the process, and must actually exercise that authority in a manner that demonstrates genuine independence from the controller. Courts have found MFW conditions unsatisfied where the special committee's advisers had material prior relationships with the controller, where committee members had preexisting business relationships with management that compromised their independence, or where the committee's conduct suggested it was a formality rather than a genuine check on the controller's proposal.
The majority-of-the-minority shareholder vote, the second MFW condition, requires that the proxy statement or tender offer disclosure provide the unaffiliated shareholders with complete and accurate information about the transaction, the special committee's process, and the basis for the board's recommendation. A majority-of-the-minority vote that was obtained through materially misleading disclosure does not satisfy the MFW condition. The interaction between MFW's cleansing effect and the adequacy of the proxy statement disclosure is therefore one of the most consequential intersections in controller transaction practice. For how this framework applies alongside the securities disclosure obligations in going-private transactions, see the guide on securities law disclosure standards.
15. Section 262 Appraisal Rights in Detail
Appraisal rights under Section 262 of the Delaware General Corporation Law give shareholders who dissent from a merger the statutory right to receive a judicial determination of the fair value of their shares. The appraisal remedy is available as an alternative to the merger consideration, not in addition to it: a shareholder who perfects appraisal rights receives the court's valuation rather than the merger price, and the court's valuation may be higher, equal to, or lower than the merger consideration depending on the evidence and the valuation methodology applied. Appraisal has become a significant litigation strategy employed by hedge funds and other institutional investors who believe the merger price undervalues the target.
The procedural requirements for perfecting appraisal rights are precise and strictly enforced. A shareholder must notify the company in writing of its intent to demand appraisal before the shareholder vote is taken, must not vote in favor of the merger (abstaining or not voting preserves appraisal rights; voting against is not required), and must hold the shares continuously through the effective date of the merger. After the merger becomes effective, the shareholder must file a petition in the Delaware Court of Chancery within 120 days of the effective date to initiate the appraisal proceeding. Failure to comply with any of these procedural requirements forfeits the right to appraisal without exception.
In an appraisal proceeding, the Court of Chancery determines the fair value of the dissenting shares as a going concern, excluding any element of value arising from the merger itself. The court has broad discretion in selecting the valuation methodology and the weight to assign to different analyses. In recent years, Delaware courts have increasingly relied on the merger price itself, or merger price minus synergies, as the best evidence of fair value when the transaction resulted from a competitive, arm's-length process, thereby reducing the premium available to appraisal petitioners who argued that the merger consideration was below intrinsic value.
Interest accrues on appraisal awards at the legal rate of 5 percent over the Federal Reserve discount rate, compounded quarterly, from the effective date of the merger through the date of payment. In cases involving large sums and extended litigation, the interest component can be material. The target company may elect to pay a portion of the merger consideration to dissenting shareholders before the appraisal proceeding concludes, which stops the accrual of interest on the paid portion and reduces the cost of an adverse appraisal outcome. This election to prepay is a strategic decision that requires evaluating the likelihood of a significant appraisal award against the cost of foregoing the ability to dispute the full award in litigation.
Appraisal arbitrage, the practice of acquiring shares after merger announcement for the purpose of perfecting appraisal rights, remains a significant feature of the public M&A landscape. The Delaware legislature has amended Section 262 to require that appraisal petitioners hold at least 1 percent of the outstanding shares or shares with a pre-appraisal value of at least $1 million to be eligible for appraisal, which has reduced the volume of very small appraisal claims but has not eliminated institutional appraisal petitions in large transactions. The risk of appraisal litigation is highest in transactions where the deal process was not fully competitive, where the deal price represented a modest premium over the pre-announcement trading price, or where credible alternative valuation methodologies produce values significantly above the merger consideration.
16. Section 203 and Other Anti-Takeover Statutes
Section 203 of the Delaware General Corporation Law is the principal anti-takeover statute applicable to Delaware corporations that have not opted out of its coverage in their certificate of incorporation. Section 203 prohibits a Delaware corporation from engaging in a business combination with an interested stockholder, defined as a stockholder who owns 15 percent or more of the corporation's outstanding voting stock, for a period of three years following the date on which the stockholder became an interested stockholder, unless specified conditions are met. The three-year moratorium effectively prevents a hostile acquirer who crosses the 15 percent threshold from completing a back-end merger or engaging in other transactions with the company during that period without satisfying the statute's conditions.
The three-year moratorium under Section 203 can be avoided in three ways. First, the board may approve the business combination or the acquisition of shares before the acquirer crosses the 15 percent threshold, which is the reason acquirers in friendly transactions often seek and obtain board approval of their share acquisitions before making a public announcement. Second, the acquirer may reach 85 percent ownership in the same transaction in which it crossed 15 percent, excluding shares held by directors who are also officers and by certain employee stock plans, which effectively requires the acquirer to achieve overwhelming shareholder support in a single tender offer. Third, the business combination may be approved at a shareholder meeting by the affirmative vote of at least two-thirds of the outstanding shares not owned by the interested stockholder.
Many states other than Delaware have enacted anti-takeover statutes that impose their own restrictions on acquisitions of domestic corporations. Pennsylvania's "control share acquisition" statute, Ohio's "control share acquisition" and "merger moratorium" provisions, and similar statutes in Massachusetts, Minnesota, and other states can apply to companies incorporated in those states and to non-Delaware corporations that have principal offices or significant operations in those states. A comprehensive anti-takeover analysis for any target company must identify all potentially applicable state statutes, not just Delaware's Section 203, and must assess whether any of them apply to the contemplated transaction.
Delaware corporations may opt out of Section 203 through a provision in their certificate of incorporation. A corporation that has opted out of Section 203 in its charter does not have the statutory protection against interested stockholder transactions, which means a hostile acquirer who crosses the 15 percent threshold faces no Section 203 moratorium. Whether to include Section 203 coverage in a corporation's charter is a governance decision typically made at the time of incorporation or at a subsequent shareholder meeting, and removing Section 203 coverage requires a charter amendment approved by a majority of outstanding shares, which may itself be difficult to obtain if a significant portion of shareholders value the anti-takeover protection.
Federal law also provides anti-takeover protection through the Williams Act, which governs tender offers and imposes procedural requirements designed to give shareholders adequate time and information to evaluate any tender offer before tendering. While the Williams Act's purpose is disclosure and fairness rather than defensive protection, its procedural requirements, including the mandatory 20-business-day offer period and the shareholders' right to withdraw tendered shares, provide target companies and their boards with time to mount a defensive response or seek a competing bid. For how these statutory defenses interact with international hostile takeover law in cross-border transactions, see the cross-border M&A legal guide.
17. Poison Pills and Defensive Tactics
A shareholder rights plan, known colloquially as a poison pill, is the most powerful defensive mechanism available to a Delaware corporation's board. Properly structured, a pill can make a hostile acquisition effectively impossible to complete without board approval, because the dilution it triggers when the acquirer crosses the pill's ownership threshold destroys the value of the acquirer's investment and makes the economics of the hostile acquisition unworkable. The pill does not permanently block acquisition: it forces the acquirer to negotiate with the board rather than acquiring shares in the market or through a tender offer that bypasses the board.
A rights plan works by distributing rights to all existing shareholders (other than the triggering acquirer) that, upon the occurrence of the trigger event, allow those shareholders to purchase additional shares of the company at a substantial discount to market price. The trigger event is typically the acquisition of shares above a defined threshold, commonly between 10 and 20 percent of outstanding shares. When the trigger occurs, the rights "flip in," allowing all shareholders except the triggering acquirer to purchase shares at half price, doubling the dilution experienced by the acquirer. This dilution makes any acquisition that does not receive the board's consent prohibitively expensive and therefore forces the acquirer to negotiate with the board for pill redemption before acquiring control.
Delaware courts evaluate rights plans under the Unocal standard when their adoption is challenged. The board must demonstrate that it had a reasonable basis to believe a threat to the corporation existed and that the pill was a reasonable response to that threat. Courts have upheld pills adopted in response to hostile bids, activist accumulation strategies, and creeping acquisition approaches where the acquirer was building a position in the market without making a formal bid. Courts have been more skeptical of pills adopted with very low trigger thresholds, pills directed at specific activists whose activities were protected expression, and pills maintained for extended periods after the initial threat had passed.
Beyond shareholder rights plans, boards have access to several other defensive tactics, including targeted share repurchases designed to increase the cost of an acquisition, recapitalization transactions that create supervoting shares held by management, staggered board provisions in the certificate of incorporation that prevent a hostile acquirer from replacing the full board in a single election, and "blank check" preferred stock provisions that authorize the board to issue preferred shares with voting rights superior to common stock. Each of these defenses carries its own Unocal analysis and shareholder relations implications, and the combination of defensive measures must be evaluated holistically rather than one at a time.
The utility of any defensive tactic is constrained by the board's ultimate fiduciary obligation to act in the best interests of shareholders. A board that uses defensive measures to perpetuate incumbent management or to block a clearly superior acquisition proposal at the expense of shareholders crosses the line from legitimate defense into entrenchment, which Delaware courts will not protect. The most effective use of defensive tactics is as temporary instruments that buy the board time to conduct a proper strategic review, run a market process, or negotiate improved terms from a bidder, not as permanent barriers to any acquisition. For how these considerations apply specifically in the context of securities law and securities offerings compliance, both bodies of law must be considered simultaneously when defensive measures involve the issuance of new securities.
18. International and Dual-Listed Company Deals
Acquisitions involving companies listed on stock exchanges in multiple countries present a distinct legal complexity: the transaction must simultaneously satisfy the disclosure and procedural requirements of each jurisdiction where the company's shares trade. A U.S. acquirer purchasing a dual-listed target must comply with U.S. securities law requirements and the laws of each foreign jurisdiction where the target's shares are listed. Conversely, a non-U.S. acquirer acquiring a U.S. public company must comply with U.S. securities law fully, even if it is accustomed to a different procedural framework in its home jurisdiction.
The U.K. City Code on Takeovers and Mergers, administered by the U.K. Takeover Panel, governs acquisitions of U.K. public companies and certain companies incorporated in other jurisdictions but listed on U.K. exchanges. The City Code imposes requirements that differ significantly from U.S. practice, including mandatory offer obligations that require an acquirer who crosses the 30 percent ownership threshold to make a cash offer to all shareholders at the highest price paid for any shares in the prior 12 months. The City Code also prescribes strict offer timetables, restricts the acquirer's ability to impose conditions to the offer, and limits deal protection arrangements in ways that would not be permitted in U.S. practice. Structuring a transaction involving a U.K.-listed target requires coordinating U.S. and U.K. counsel from the earliest stages of the transaction.
The SEC provides certain accommodations for cross-border tender offers to reduce the compliance burden on issuers navigating multiple regulatory frameworks simultaneously. Tier 1 and Tier 2 cross-border exemptions under Rules 14d-1(c) and (d) modify certain tender offer requirements for offers to U.S. holders of foreign private issuers, based on the percentage of outstanding shares held by U.S. persons. Transactions in which U.S. shareholders hold 10 percent or less of the target's outstanding shares receive the broadest accommodations, while transactions in which U.S. holders represent more than 40 percent of outstanding shares receive more limited relief. Calculating U.S. holder percentages and determining the applicable tier is a threshold compliance task in any cross-border tender offer.
Regulatory approvals in cross-border transactions are often the primary driver of deal timeline, because the parties must secure clearance from antitrust authorities in each jurisdiction where the transaction meets the applicable filing threshold. The EU Merger Regulation, which applies to transactions affecting competition in the European Economic Area above defined turnover thresholds, imposes notification requirements and a review process with its own timeline and substantive standards that may differ from the U.S. HSR process. In transactions requiring both U.S. and EU regulatory approval, coordinating the two review processes and managing the uncertainty of their concurrent timelines is one of the most complex project management challenges in cross-border M&A.
Tax and structuring considerations add another layer of complexity in cross-border public company acquisitions. The choice between a forward merger, a reverse merger, a tender offer, or a scheme of arrangement under English law has significant tax consequences for the acquirer, the target shareholders, and the combined entity. Transfer taxes, stamp duties, and withholding tax obligations on dividends and interest payments in the combined structure must be modeled before the transaction structure is finalized. The comprehensive legal framework for cross-border transactions, including jurisdiction-specific regulatory requirements and structural tax considerations, is addressed in the cross-border M&A legal guide.
19. Representations and Warranties in Public Company Deals
Public company merger agreements contain a substantially narrower and less heavily negotiated set of representations and warranties than private company purchase agreements. This difference reflects the fundamental asymmetry between the two transaction types: in a private company deal, the buyer is purchasing a company that it has evaluated primarily through diligence materials provided by the seller, and the representations and warranties serve as the seller's allocation of risk for facts that the buyer could not independently verify. In a public company deal, the buyer has access to years of SEC filings that describe the target's business, financial condition, risks, and legal proceedings in far greater detail than most private company sellers would voluntarily provide.
The principal target representations in a public company merger agreement address corporate existence and authority, the validity of the merger agreement and its enforceability, the accuracy of SEC filings and financial statements, the absence of material undisclosed liabilities, the capitalization of the company (share counts, options, warrants, and convertible instruments), the absence of material adverse changes since the most recent balance sheet date, compliance with material contracts, environmental compliance, tax matters, employee benefits, labor relations, and the absence of material litigation. Each of these representations is qualified by a material adverse effect standard that limits the scope of the representation to matters that would or would reasonably be expected to have a material adverse effect on the target.
The definition of "material adverse effect" is the most extensively negotiated provision in a public company merger agreement, because it determines the circumstances under which the acquirer may decline to close the transaction based on a change in the target's condition that occurred between signing and closing. A standard material adverse effect definition includes a general statement that any change, event, development, or occurrence that has or would reasonably be expected to have a material adverse effect on the business, financial condition, or results of operations of the target constitutes a material adverse effect, subject to a list of carve-outs for events that are excluded from the definition even if they would otherwise meet the threshold.
The carve-outs to the material adverse effect definition are as important as the definition itself. Standard carve-outs exclude changes in general economic conditions, changes in financial markets, changes affecting the target's industry generally, changes in applicable law or accounting standards, the announcement of the merger agreement itself and its effect on the target's business, and actions taken with the acquirer's written consent. Carve-outs for general economic conditions and industry changes may themselves be subject to a "disproportionate effect" exception, which includes events that fall within a carve-out category in the definition if they disproportionately affect the target relative to comparable companies in the same industry.
Representations and warranty insurance, which is standard in private company acquisitions, is rarely used in public company transactions because the target's representations are narrow, the survival period is short (or the representations do not survive closing at all), and the target shareholders who receive merger consideration are not party to the merger agreement and cannot be held responsible for indemnification. The post-closing liability framework in public company deals is therefore fundamentally different from private company deals: the acquirer's recourse for breaches discovered after closing is generally limited to the legal remedies available for fraud or to claims under federal securities law for material misstatements in the proxy statement or SEC filings, rather than to contractual indemnification. For a comparison of how representations are structured across transaction types, see the broader guide to M&A deal structures.
20. Working with Acquisition Stars on Public Company M&A
Public company M&A transactions operate at the intersection of Delaware corporate law, federal securities regulation, antitrust law, and financial market practice. The legal process is demanding, the disclosure obligations are extensive, and the litigation environment is unforgiving of process failures. Counsel in these transactions must be comfortable working across all of these disciplines simultaneously, coordinating with investment bankers, accountants, and the client's internal team on a compressed timeline while maintaining the discipline to get every disclosure detail right.
Acquisition Stars, led by Alex Lubyansky, brings M&A and securities law experience to public company transactions across the full deal cycle. On the buy side, the firm advises acquirers on transaction structure, regulatory filing obligations, HSR and antitrust pre-clearance strategy, and the mechanics of the tender offer or merger proxy process. On the sell side, the firm advises target boards and special committees on fiduciary duty compliance, deal protection device design, fairness opinion oversight, and the management of shareholder litigation risk from the announcement of a strategic review through the closing of the transaction.
Every engagement begins with a structured assessment of the transaction's legal requirements, the applicable fiduciary duty standard, the anticipated regulatory filing timeline, and the principal risk factors in the specific deal. That assessment shapes the legal strategy before any process is launched, so that the transaction documentation, the board's deliberative process, and the market check approach are all designed from the outset to satisfy the applicable legal standards and to withstand the scrutiny that follows public announcement. The goal is not merely to complete the transaction but to complete it in a way that produces a defensible record of the board's conduct and the adequacy of its process.
Acquisition Stars is based in Novi, Michigan, and serves clients nationally on M&A and securities law matters. The firm's practice encompasses not only public company M&A but also the full spectrum of M&A transaction structures for both strategic and financial acquirers, as well as securities offerings that frequently accompany M&A transactions, including registered offerings by public acquirers, Rule 144A placements, and Regulation D private placements in acquisition financing contexts. The integration of M&A and securities law capabilities within a single firm allows for coordinated advice across the deal structure, financing, and regulatory compliance dimensions of a transaction.
To discuss a potential public company acquisition, take-private, or strategic review, contact Acquisition Stars at consult@acquisitionstars.com, 248-266-2790, or through the engagement form below. Initial inquiries are evaluated to determine whether the firm's capabilities and capacity align with the transaction's requirements. Acquisition Stars is located at 26203 Novi Road Suite 200, Novi MI 48375.
Frequently Asked Questions: Public Company M&A
What is the primary legal difference between a public company merger and a private company acquisition?
Public company acquisitions are governed by a set of overlapping federal securities law requirements, SEC disclosure obligations, and state corporate law fiduciary standards that have no direct equivalent in private transactions. The target board must satisfy enhanced fiduciary duty standards under Delaware law, the transaction requires either a shareholder vote on a proxy statement or a tender offer filed on Schedule TO, and every material fact about the transaction must be publicly disclosed in documents reviewed by the SEC. Private deals move faster and with less disclosure, but public deals demand a more structured legal process from the moment the board authorizes a strategic review.
What does it mean for a board to trigger Revlon duties?
Revlon duties arise when a board decides to sell control of the corporation or initiates a breakup of the company, shifting the board's obligation from preserving corporate independence to maximizing immediate shareholder value in the sale. Under the Delaware Supreme Court's decision in Revlon, Inc. v. MacAndrews and Forbes Holdings, the board in that posture must seek the best available price for shareholders and cannot favor the interests of managers, particular bidders, or other constituencies at shareholders' expense. Whether Revlon applies depends on the transaction structure: a merger into an acquirer in which shareholders receive cash triggers Revlon, while a stock-for-stock merger in which shareholders retain a continuing equity interest in the surviving entity may not.
What is the Unocal standard and when does it apply?
The Unocal standard applies when a target board adopts defensive measures in response to an actual or threatened acquisition attempt. Under Unocal Corp. v. Mesa Petroleum Co., a board that takes defensive action must demonstrate that it had reasonable grounds to believe a threat to corporate policy and effectiveness existed and that the defensive response was reasonable in relation to the threat posed. Courts scrutinize defensive measures adopted under Unocal more carefully than ordinary business decisions, and measures that are coercive or preclusive are invalid regardless of their justification. Unocal is the doctrinal foundation for evaluating poison pills, targeted share repurchases, and other takeover defenses.
What is the difference between a one-step merger and a two-step tender offer?
In a one-step merger, the acquirer and target execute a merger agreement, the target mails a proxy statement, shareholders vote, and the merger closes in a single step governed by the applicable corporation statute. In a two-step structure, the acquirer first launches a tender offer to purchase shares directly from target shareholders, then merges out the remaining minority through a short-form or long-form back-end merger once it has accumulated sufficient ownership. The two-step structure can deliver consideration to tendering shareholders in as few as 20 business days after the tender offer opens, while a one-step merger typically requires three to four months from signing to close due to the proxy statement process and SEC review.
What is Rule 13e-3 and which transactions trigger it?
Rule 13e-3 under the Securities Exchange Act governs going-private transactions in which an affiliate of the issuer takes the company private, causing the issuer's securities to be deregistered or its obligation to file Exchange Act reports to be suspended. Transactions that trigger Rule 13e-3 include tender offers by affiliates, mergers with affiliates, and purchases by the issuer that would result in fewer than 300 holders of record. The filing requirements under Rule 13e-3 include the Schedule 13E-3, which must be filed at the time the transaction is announced and updated through completion, and which requires detailed disclosure of the transaction's purposes, effects, alternatives considered, and the fairness of the terms to unaffiliated shareholders.
What SEC filings are required in a public company acquisition?
The specific filing requirements depend on the transaction structure. A one-step merger with a shareholder vote requires the target to file a proxy statement on Schedule 14A and the acquirer to file a registration statement on Form S-4 if it is issuing its own securities as consideration. A two-step tender offer requires the acquirer to file a Schedule TO and the target to file a Schedule 14D-9 within ten business days after the offer commences. Going-private transactions also require a Schedule 13E-3. Each of these documents is reviewed by the SEC's Division of Corporation Finance, and the SEC's comment process can add weeks or months to the transaction timeline depending on the complexity of the disclosure.
What is a go-shop provision and how does it work?
A go-shop provision in a merger agreement gives the target board the right to actively solicit competing acquisition proposals for a defined period after signing, typically 20 to 45 days. During the go-shop period, the target may share confidential information with potential competing bidders and negotiate with them without breaching the no-shop covenant that otherwise governs the period between signing and close. If a competing bidder emerges during the go-shop period and satisfies certain conditions, the target may be subject to a reduced break-up fee when terminating the original agreement to accept the superior proposal. Go-shops are used most frequently in take-private transactions where the initial process was not a broad auction and the board wants to demonstrate it satisfied its Revlon obligations after signing.
What are Section 262 appraisal rights and when do they matter?
Section 262 of the Delaware General Corporation Law gives shareholders who do not vote in favor of a merger the right to seek judicial appraisal of the fair value of their shares rather than accepting the merger consideration. Shareholders who perfect appraisal rights receive the court's determination of fair value, which may be higher or lower than the merger price depending on the valuation methodology applied and the evidence presented. Appraisal rights have become a significant litigation tool in public company M&A, with hedge funds and arbitrageurs using them to seek premium recoveries in transactions where they believe the merger price understates intrinsic value. The risk of appraisal litigation affects deal protection device design, the break-up fee structure, and the pricing analysis conducted by the target's financial advisers.
What is the MFW standard in controller conflict transactions?
The MFW framework, derived from the Delaware Supreme Court's decision in Kahn v. M&F Worldwide Corp., provides a path for transactions between a controlled company and its controlling shareholder to receive business judgment review rather than the more demanding entire fairness standard. To qualify for MFW protection, the transaction must be conditioned ab initio on approval by both a special committee of independent directors with full negotiating authority and a majority-of-the-minority shareholder vote, and the special committee must have actually functioned independently and effectively. If both procedural conditions are satisfied, the court reviews the transaction under the deferential business judgment standard, effectively making the transaction nearly impossible to challenge on the merits.
What is a poison pill and how does it defend against hostile takeovers?
A shareholder rights plan, commonly called a poison pill, is a defensive mechanism adopted by a board that makes a hostile acquisition prohibitively expensive by allowing all shareholders except the acquiring person to purchase additional shares at a substantial discount once the acquirer crosses a defined ownership threshold. The dilution triggered by the pill effectively prevents an acquirer from accumulating enough shares to control the company without board approval. Modern pills can be adopted quickly without shareholder approval, but Delaware courts scrutinize pill terms under the Unocal standard and have required boards to redeem pills when their continued maintenance was found disproportionate to the threat. Pills are most effective as a temporary defensive measure that buys the board time to evaluate alternatives.
What reps and warranties are customary in public company acquisition agreements?
Public company merger agreements contain a narrower set of representations and warranties than private company purchase agreements, reflecting the fact that most of the target's material information has already been disclosed in its public filings and is available to the acquirer through its due diligence on those filings. Customary target reps cover corporate organization and authority, capitalization, the accuracy of SEC filings, the absence of undisclosed liabilities, material contracts, absence of litigation, and no-conflicts with existing obligations. A critical feature unique to public company deals is that the representations are qualified by a material adverse effect carve-out, which allocates deal risk by defining the types of adverse developments that excuse the acquirer from closing versus those that are part of the bargained risk of the transaction.
How does Acquisition Stars approach public company M&A engagements?
Acquisition Stars brings M&A and securities law experience to public company transactions across the full deal lifecycle, from initial board-level strategic review through SEC filing preparation, shareholder vote or tender offer process, and closing mechanics. Alex Lubyansky advises on deal structure selection, fiduciary duty compliance, deal protection device design, and regulatory filing strategy tailored to the specific transaction. Engagements begin with a structured transaction assessment that maps the applicable legal requirements to the client's business objectives before any process is launched. To discuss a potential transaction, contact the firm at consult@acquisitionstars.com or 248-266-2790.